NEW YORK, April 5 (Reuters) – Valeant Pharmaceuticals International is offering to pay lenders a higher interest rate than initially proposed after some investors threatened to block an amendment the…
The post LPC: Valeant hikes premium to lenders to avert default appeared first on NASDAQ.